Studies have shown that upon virus infection, MLL5 is translocated from the nucleus to the cytoplasm, and part of MLL5 interacts with RIG-I and E3 CHIP to boost CHIP to catalyze the K48-linked ubiquitination of RIG-I, thereby inhibiting innate immunity (116). This evidence concerns the gene KMT2E and viral infectious disease.